Literature DB >> 35923526

Post trans-catheter aortic valve replacement shock: Back to the basics.

Ali Z Zgheib1, Dounia Z Iskandarani1, Jennifer Jdaidani1, Fadi J Sawaya1.   

Abstract

Transcatheter aortic valve replacement (TAVR) is indicated for the treatment of patients with severe aortic stenosis (AS) at low, intermediate, and high risk. Immediate complications post-TAVR that lead to hemodynamic compromise include: retroperitoneal bleeding, aortic dissection or rupture, pericardial tamponade, coronary ostial obstruction, acute severe central or paravalvular regurgitation, heart block, and suicide left ventricle. The presence of significant paravalvular leak (PVL) after TAVR is now an uncommon complication with newer generation devices. We present a case of an 82-year-old frail female patient who presented to our clinic with dyspnea upon minimal exertion and orthopnea. She was found to have severe AS that was treated with TAVR. The procedure was complicated by hemodynamic compromise due to severe PVL and left ventricular outflow tract (LVOT) obstruction which was underestimated by transthoracic echocardiography. The PVL was eventually treated with a vascular plug device and the LVOT obstruction was treated with alcohol septal ablation. This case highlights the vital role of early and aggressive work up in unstable patients post-TAVR and the importance of transesophageal echocardiography in patients with unexplained hypotension post-TAVR to unmask the severe PVL and dynamic LVOT obstruction. <Learning objective: Early and aggressive work-up is necessary in unstable patients post-transcatheter aortic valve replacement. Anesthesia is needed in high-risk cases to quickly deal with hemodynamic changes. Transesophageal echocardiography is particularly required when a patient develops unexplained hypotension as it can unmask severe paravalvular leak and dynamic left ventricular outflow obstruction.>.
© 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aortic valve disease; Aortic valve disease percutaneous intervention; Paravalvular leak; Shock cardiogenic; Structural heart disease intervention; Transcatheter valve implantation

Year:  2022        PMID: 35923526      PMCID: PMC9214805          DOI: 10.1016/j.jccase.2022.01.007

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  6 in total

Review 1.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson
Journal:  Circulation       Date:  2017-03-15       Impact factor: 29.690

2.  Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation.

Authors:  Jan-Malte Sinning; Christoph Hammerstingl; Mariuca Vasa-Nicotera; Viktoria Adenauer; Sisa Josefina Lema Cachiguango; Anne-Cathérine Scheer; Sven Hausen; Alexander Sedaghat; Alexander Ghanem; Cornelius Müller; Eberhard Grube; Georg Nickenig; Nikos Werner
Journal:  J Am Coll Cardiol       Date:  2012-03-27       Impact factor: 24.094

3.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.

Authors:  Michael J Mack; Martin B Leon; Craig R Smith; D Craig Miller; Jeffrey W Moses; E Murat Tuzcu; John G Webb; Pamela S Douglas; William N Anderson; Eugene H Blackstone; Susheel K Kodali; Raj R Makkar; Gregory P Fontana; Samir Kapadia; Joseph Bavaria; Rebecca T Hahn; Vinod H Thourani; Vasilis Babaliaros; Augusto Pichard; Howard C Herrmann; David L Brown; Mathew Williams; Jodi Akin; Michael J Davidson; Lars G Svensson
Journal:  Lancet       Date:  2015-03-15       Impact factor: 79.321

4.  Concomitant septal myectomy in patients undergoing aortic valve replacement for severe aortic stenosis.

Authors:  Ju Yong Lim; Jin Oh Choi; Jae Kon Oh; Zhou Li; Soon J Park
Journal:  Circ J       Date:  2014-12-15       Impact factor: 2.993

5.  Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Michael J Reardon; Nicolas M Van Mieghem; Jeffrey J Popma; Neal S Kleiman; Lars Søndergaard; Mubashir Mumtaz; David H Adams; G Michael Deeb; Brijeshwar Maini; Hemal Gada; Stanley Chetcuti; Thomas Gleason; John Heiser; Rüdiger Lange; William Merhi; Jae K Oh; Peter S Olsen; Nicolo Piazza; Mathew Williams; Stephan Windecker; Steven J Yakubov; Eberhard Grube; Raj Makkar; Joon S Lee; John Conte; Eric Vang; Hang Nguyen; Yanping Chang; Andrew S Mugglin; Patrick W J C Serruys; Arie P Kappetein
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

6.  Comparison of transesophageal and transthoracic echocardiography under moderate sedation for guiding transcatheter aortic valve replacement.

Authors:  Ines Sherifi; Alaa Mabrouk Salem Omar; Mithun Varghese; Menachem Weiner; Ani Anyanwu; Jason C Kovacic; Samin Sharma; Annapoorna Kini; Partho P Sengupta
Journal:  Echo Res Pract       Date:  2018-05-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.